PF-05212372

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-05212372, covering 2011-08-15 to 2011-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372. [Phase 1]

See pricing